ZIIHERA β JAZZ PHARMS, approved 2024-11-20 (BLA761416).
44 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.